- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting CD276 for T cell-based immunotherapy of breast cancer ; volume:22 ; number:1 ; day:4 ; month:10 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (4.10.2024), 1-15, 12.2024
- Creator
-
Hagelstein, Ilona
Wessling, Laura
Rochwarger, Alexander
Zekri, Latifa
Klimovich, Boris
Tegeler, Christian M.
Jung, Gundram
Schürch, Christian M.
Salih, Helmut R.
Lutz, Martina S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05689-4
- URN
-
urn:nbn:de:101:1-2412202112418.075797395289
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hagelstein, Ilona
- Wessling, Laura
- Rochwarger, Alexander
- Zekri, Latifa
- Klimovich, Boris
- Tegeler, Christian M.
- Jung, Gundram
- Schürch, Christian M.
- Salih, Helmut R.
- Lutz, Martina S.
- SpringerLink (Online service)
Other Objects (12)
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
CD8+ T cell-based cancer immunotherapy
p16INK4a as target for T cell-based cancer immunotherapy
Targeting STAT3 in Cancer Immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Targeting adenosine for cancer immunotherapy
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
P14. Cell-based gene delivery leverages conventional immunotherapy for cancer
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Immunotherapy targeting esophageal cancer stem cells